These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 28911822

  • 1. Structural insights of cyclin dependent kinases: Implications in design of selective inhibitors.
    Kalra S, Joshi G, Munshi A, Kumar R.
    Eur J Med Chem; 2017 Dec 15; 142():424-458. PubMed ID: 28911822
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Recent advances on CDK inhibitors: An insight by means of in silico methods.
    Tutone M, Almerico AM.
    Eur J Med Chem; 2017 Dec 15; 142():300-315. PubMed ID: 28802482
    [Abstract] [Full Text] [Related]

  • 4. Loop flexibility and solvent dynamics as determinants for the selective inhibition of cyclin-dependent kinase 4: comparative molecular dynamics simulation studies of CDK2 and CDK4.
    Park H, Yeom MS, Lee S.
    Chembiochem; 2004 Dec 03; 5(12):1662-72. PubMed ID: 15505811
    [Abstract] [Full Text] [Related]

  • 5. Selectivity and potency of cyclin-dependent kinase inhibitors.
    Sridhar J, Akula N, Pattabiraman N.
    AAPS J; 2006 Mar 24; 8(1):E204-21. PubMed ID: 16584130
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cyclin-dependent protein kinases as therapeutic drug targets for antimalarial drug development.
    Waters NC, Geyer JA.
    Expert Opin Ther Targets; 2003 Feb 24; 7(1):7-17. PubMed ID: 12556199
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification and structural-functional analysis of cyclin-dependent kinases of the cattle tick Rhipicephalus (Boophilus) microplus.
    Gomes H, Romeiro NC, Braz GR, de Oliveira EA, Rodrigues C, da Fonseca RN, Githaka N, Isezaki M, Konnai S, Ohashi K, da Silva Vaz I, Logullo C, Moraes J.
    PLoS One; 2013 Feb 24; 8(10):e76128. PubMed ID: 24146826
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Understanding and modulating cyclin-dependent kinase inhibitor specificity: molecular modeling and biochemical evaluation of pyrazolopyrimidinones as CDK2/cyclin A and CDK4/cyclin D1 inhibitors.
    Rossi KA, Markwalder JA, Seitz SP, Chang CH, Cox S, Boisclair MD, Brizuela L, Brenner SL, Stouten PF.
    J Comput Aided Mol Des; 2005 Feb 24; 19(2):111-22. PubMed ID: 16075305
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16.
    Dixon-Clarke SE, Shehata SN, Krojer T, Sharpe TD, von Delft F, Sakamoto K, Bullock AN.
    Biochem J; 2017 Feb 20; 474(5):699-713. PubMed ID: 28057719
    [Abstract] [Full Text] [Related]

  • 19. Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin.
    Lu H, Chang DJ, Baratte B, Meijer L, Schulze-Gahmen U.
    J Med Chem; 2005 Feb 10; 48(3):737-43. PubMed ID: 15689157
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.